MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s11686-025-01212-x

Медицинская библиотека · Acta parasitologica · 2026

Sero-evidence of Latent Toxoplasma Gondii Infection in Cancer Patients Before and After Chemotherapy, Northern Iran.

Shekarriz Ramin, Azari Noor Nakisa, Hosseininezhad Zahra, Nazar Eisa, Eslami Jouybari Mohammad, Zaboli Ehsan, Ghasemi Maryam, Sharifpour Ali, Fakhar Mahdi

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Toxoplasmosis, caused by Toxoplasma gondii, affects a significant proportion of the global population. While typically asymptomatic in healthy individuals due to effective immune responses, immunocompromised individuals, such as cancer patients undergoing chemotherapy, are at risk of developing acute toxoplasmosis due to the reactivation of latent infection. This study aims to investigate the seroprevalence of latent T. gondii infection among cancer patients who were registered with the Iranian National Registry Center for Toxoplasmosis (INRCT), before and after chemotherapy, and to determine the relationship between chemotherapy and IgG antibody responses.

PATIENTS AND

METHODS

This cross-sectional study investigated the seroprevalence of T. gondii infection and its relationship with chemotherapy in 107 cancer patients with solid organ tumors. Participants were recruited from oncology centers in Sari, northern Iran, between 2023 and 2024 and were assessed for anti-T. gondii IgG and IgM antibodies using ELISA before and three weeks after chemotherapy initiation.

RESULTS

At baseline, 80.4% of patients were IgG positive, indicating prior T. gondii exposure. Three weeks post-chemotherapy, 28.92% showed a significant increase in IgG titers. While age was significantly associated with Toxoplasma infection at baseline (P < 0.05), no significant associations were found between demographic or clinical characteristics and IgG seropositivity or titer changes post-chemotherapy. Breast cancer patients exhibited the highest prevalence of Toxoplasma IgG.

CONCLUSIONS

These findings suggest a high prevalence of latent toxoplasmosis in cancer patients, with chemotherapy potentially influencing IgG titers in a subset of individuals, independent of other factors examined. Further research is needed to elucidate the underlying mechanisms and clinical implications of these observations.

Для цитирования: Shekarriz Ramin, Azari Noor Nakisa, Hosseininezhad Zahra, Nazar Eisa, Eslami Jouybari Mohammad, Zaboli Ehsan, Ghasemi Maryam, Sharifpour Ali, Fakhar Mahdi. Sero-evidence of Latent Toxoplasma Gondii Infection in Cancer Patients Before and After Chemotherapy, Northern Iran.. Acta parasitologica. 2026. DOI: 10.1007/s11686-025-01212-x.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.